Scientists design non-hallucinogenic psychedelic treatments potentially accelerating research on mental health benefits

Researchers identified 5-hydroxytryptamine 2A (5-HT2A) receptor (5-HT2AR) signaling pathways associated with psychedelic potential.

Related Keywords

Synthex Shutterstock ,Nature Communications ,Mental Health ,Research ,Agonist ,Anxiety ,Efficacy ,Pcr ,Migand ,Harmacology ,Reclinical ,Protein ,Eceptor ,